CytoMed Therapeutics Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GDTC research report →
Companyw2.cytomed.sg
CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers. The company's lead product candidate is CTM-N2D, which consists of expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor to improve anti-cancer cytotoxicity. It is also developing iPSC-gdNKT, which utilizes iPSC as a starting material to generate gdNKT, a synthetic hybrid of a gamma delta T cell and a NK cell; and CTM-GDT, a product candidate that consists of expanded gamma delta T cells, and exploits the multiple recognition system of gamma delta T cell to recognize and treat a range of cancers.
- CEO
- Chee Kong Choo
- IPO
- 2023
- Employees
- 43
- HQ
- Singapore, SG
Price Chart
Valuation
- Market Cap
- $15.62M
- P/E
- -3.44
- P/S
- 36.66
- P/B
- 2.38
- EV/EBITDA
- -3.28
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -63.95%
- Op Margin
- -1075.12%
- Net Margin
- -1062.06%
- ROE
- -75.27%
- ROIC
- -62.45%
Growth & Income
- Revenue
- $319.20K · 513.79%
- Net Income
- $-3,916,834 · -107.99%
- EPS
- $-0.33 · -106.25%
- Op Income
- $-4,519,770
- FCF YoY
- -46.22%
Performance & Tape
- 52W High
- $3.68
- 52W Low
- $0.68
- 50D MA
- $1.00
- 200D MA
- $1.50
- Beta
- -0.17
- Avg Volume
- 16.14K
Get TickerSpark's AI analysis on GDTC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | Yew Chak Hua | other | 0 |
| Mar 18, 26 | Leong Mark Kei Wei | other | 0 |
| Mar 18, 26 | Choo Chee Kong | other | 0 |
| Mar 18, 26 | Choo Chee Kong | other | 0 |
| Mar 18, 26 | Choo Chee Kong | other | 0 |
| Mar 18, 26 | TAN YOONG YING | other | 0 |
| Mar 18, 26 | Goh Yvonne | other | 0 |
Our GDTC Coverage
We haven't published any research on GDTC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GDTC Report →